These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21178054)

  • 1. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer.
    Yoshida S; Masuda H; Ishii C; Tanaka H; Fujii Y; Kawakami S; Kihara K
    AJR Am J Roentgenol; 2011 Jan; 196(1):110-6. PubMed ID: 21178054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.
    Akita H; Jinzaki M; Kikuchi E; Sugiura H; Akita A; Mikami S; Kuribayashi S
    AJR Am J Roentgenol; 2011 Nov; 197(5):1130-6. PubMed ID: 22021505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of upper urinary tract cancer: using conventional MRI and diffusion-weighted MRI with different b values.
    Wu GY; Lu Q; Wu LM; WenKong ; Chen XX; Xu JR
    Acta Radiol; 2014 Sep; 55(7):882-9. PubMed ID: 24092760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?
    Watanabe H; Kanematsu M; Kondo H; Goshima S; Tsuge Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2009 May; 192(5):1361-6. PubMed ID: 19380561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
    Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
    AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging of urinary epithelial cancer with upper urinary tract obstruction: preliminary results.
    Takeuchi M; Matsuzaki K; Kubo H; Nishitani H
    Acta Radiol; 2008 Dec; 49(10):1195-9. PubMed ID: 19031182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
    Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
    J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
    Kuang F; Yan Z; Li H; Feng H
    J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
    Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
    Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
    Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
    J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion.
    Takeuchi M; Matsuzaki K; Nishitani H
    Acta Radiol; 2009 Oct; 50(8):947-53. PubMed ID: 19724949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of qualitative and quantitative evaluation of diffusion-weighted MRI and chemical-shift imaging in the differentiation of benign and malignant vertebral body fractures.
    Geith T; Schmidt G; Biffar A; Dietrich O; Dürr HR; Reiser M; Baur-Melnyk A
    AJR Am J Roentgenol; 2012 Nov; 199(5):1083-92. PubMed ID: 23096183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
    Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
    AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.